Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1365 of 6351
-
Virtual stenting tech aims to improve heart artery procedures
Disease control Recruiting nowCoronary angiography-guided percutaneous coronary intervention (PCI) remains the standard treatment strategy for patients with coronary artery disease; however, suboptimal post-PCI physiological outcomes remain common and are associated with adverse cardiovascular prognosis. Quan…
Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Could a common gout pill save legs and lives?
Disease control Recruiting nowChronic limb-threatening ischemia (CLTI) is the most severe form of peripheral artery disease, a condition in which narrowed or blocked arteries reduce blood flow to the legs. People with CLTI may have severe leg pain at rest, non-healing wounds, or gangrene, and face a high risk…
Phase 3 • Sponsor: Shin Kong Wu Ho-Su Memorial Hospital • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Brain pacemaker trial aims to help Parkinson's patients move better
Disease control By invitation onlyIntroduction: Parkinson's Disease (PD) is a progressive neurodegenerative condition characterized by classic motor symptoms, such as bradykinesia, rigidity, resting tremor, and postural instability, which directly compromise the mobility and autonomy of individuals with PD. Furth…
Sponsor: Federal University of Minas Gerais • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New antibody WIN378 aims to tame COPD lung inflammation
Disease control Recruiting nowThis study is trying to identify the right dose of a long-acting medicine called WIN378 for people with moderate - severe chronic obstructive pulmonary disease (COPD). WIN378 blocks the action of a protein called TSLP that causes inflammation in the lung and may contribute to COP…
Phase 2 • Sponsor: Windward Bio • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Talking it out in the ICU may stop PTSD after heart surgery
Prevention Recruiting nowThis clinical trial aims to evaluate whether an ICU-based preventive narrative exposure intervention can help prevent posttraumatic stress symptoms in adult patients after cardiac surgery with cardiopulmonary bypass. The study will include adult patients who undergo cardiac surg…
Sponsor: First Affiliated Hospital of Fujian Medical University • Aim: Prevention
Last updated Aug 14, 2026 00:00 UTC
-
New drug SKB118 aims to shrink Hard-to-Treat tumors
Disease control Not yet recruitingThis is a phase 1/2 clinical study to evaluate the safety and efficacy of SKB118 in participants with advanced solid tumors. The study includes a dose escalation stage, a dose expansion stage, and a indication expansion stage.
Phase 1/2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New scan could spot hidden heart risk in kidney patients
Diagnosis Not yet recruitingPatients with chronic kidney disease (CKD) have a markedly increased cardiovascular risk, with coronary artery disease being a leading cause of morbidity and mortality. Conventional cardiovascular risk scores and non-invasive diagnostic tests have limited accuracy in this populat…
Sponsor: University Hospital, Grenoble • Aim: Diagnosis
Last updated Jun 27, 2026 12:33 UTC
-
Could insulin eye drops save your sight? new trial launches
Disease control Not yet recruitingThis study evaluates the safety and preliminary efficacy of topical sterile human insulin eye drops (EYED-002) in patients with open-angle glaucoma. The study uses a phase 1/2 dose-escalation design followed by a masked, randomized, placebo-controlled phase. Insulin is formulated…
Phase 1/2 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Gut germs for brain gains: probiotic trial aims to boost preterm baby development
Disease control Not yet recruitingThe purpose of this randomized controlled trial is to evaluate the effect of daily supplementation with a probiotic mixture on the neurodevelopmental outcomes of preterm infants with a history of neonatal antibiotic exposure. The intervention lasts for 6 months. The study hypothe…
Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Pee power: simple urine test could revolutionize heart failure care
Disease control Not yet recruitingThe SURE-HF trial is a pragmatic, multicentre, randomized controlled study evaluating natriuresis-guided optimization of intravenous loop diuretic therapy in patients hospitalized with worsening heart failure (WHF). The study aims to determine whether serial urinary sodium assess…
Sponsor: Nurgul Ablakimova • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New drug cocktail aims at resistant lung cancer
Disease control Not yet recruitingThis single-arm phase II study aims to evaluate the efficacy and safety of lomustine combined with anlotinib in patients with extensive-stage small cell lung cancer resistant to second-line and above systemic treatment.
Phase 2 • Sponsor: Yayi He • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New pill aims to bring back color to vitiligo skin
Disease control Not yet recruitingThe purpose of this clinical trial is to learn how well ACT-777991 works, how safe it is and how well it is tolerated by adults with non-segmental vitiligo. The main question this clinical trial aims to answer is: • Can ACT-777991 help return color to the skin of the face of ad…
Phase 2 • Sponsor: Idorsia Pharmaceuticals Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New cocktail of old drugs takes on advanced cancers
Disease control Recruiting nowThis is an open label phase II study using metronomic low-dose gemcitabine and mitomycin c given intravenously, and thalidomide administered orally, for patients with advanced solid tumors.
Phase 2 • Sponsor: Sarcoma Oncology Research Center, LLC • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New PET scan tracer aims to spot blood cancers more clearly
Diagnosis Recruiting nowThe goal of this clinical trial is to evaluate the biodistribution, radiation dosimetry, safety, and time-dependent image quality of \^68\^Ga-EV203 injection in patients with hematological malignancies (multiple myeloma, non-Hodgkin lymphoma, or acute myeloid leukaemia), aged 18-…
Sponsor: Zhejiang Cancer Hospital • Aim: Diagnosis
Last updated Jun 28, 2026 00:00 UTC
-
New hope for rare bleeding disorder: coagadex trial targets AL amyloidosis
Disease control CancelledThe purpose of this study is to evaluate the efficacy and safety of Coagadex in treating active bleeds and to manage peri-operative bleeding in participants with acquired factor X deficiency associated with AL amyloidosis.
Phase 3 • Sponsor: Kedrion S.p.A. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Wearable Brain-Zapping device aims to ease Period-Related mood and brain fog
Symptom relief Recruiting nowThis study evaluates the feasibility and efficacy of the Samphire Guided Care (SGC) program * a 12-week structured digital health program combining clinician-led onboarding, at-home neuromodulation using the Lutea tDCS device, neuromodulation coach support, and app-based symptom…
Sponsor: Samphire Group, Inc. • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Glowing dye could save voices in esophageal cancer surgery
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether the application of indocyanine green near-infrared imaging system can accurately locate the recurrent laryngeal nerve (RLN) during lymph node dissection in esophageal cancer radical surgery, thereby reducing the risk of RLN inju…
Phase 3 • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Personalized blood pressure after stroke could boost recovery
Disease control Not yet recruitingThe RESCUE-BP is a multi-centered, prospective, randomized, open label, blinded endpoint (PROBE) phase III trial. In patients with acute ischemic stroke who have undergone endovascular treatment and achieved successful recanalization, the evaluation will compare a stratified bloo…
Phase 3 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Massive chicago study aims to curb opioid deaths with smarter screening
Knowledge-focused Not yet recruitingThis study, called the Chicago Data-driven Opioid use disorder Screening, Engagement, Treatment and Planning (C-DOSETaP) System, tests a new system of clinical care for patients with opioid use disorder (OUD) across a large health system. The main questions this study aims to an…
Sponsor: University of Illinois at Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
New eye drops could help kids with lazy eye that Won't go away
Disease control Not yet recruitingThe goal of this clinical trial is to see if a medicine called echothiophate iodide (Phospholine Iodide) can help treat children with refractory amblyopia. Amblyopia (also called lazy eye) is when one eye doesn't see as well as it should because the brain isn't using that eye cor…
Phase 2 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC